ArticleCancers2022

Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell Lymphoma.

Seok Jin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.